Neurocrine Bioscience buy Morgan Stanley
Start price
05.09.25
/
50%
€121.85
Target price
05.09.26
€139.74
Performance (%)
1.48%
Price
19.09.25
€123.65
Summary
This prediction is currently active. With a performance of 1.48%, the BUY prediction by Morgan_Stanley for Neurocrine Bioscience is trending in the right direction. This prediction currently runs until 05.09.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | 2.275% |
| iShares Core DAX® | -0.234% |
| iShares Nasdaq 100 | 2.073% |
| iShares Nikkei 225® | 1.244% |
| iShares S&P 500 | 1.133% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Morgan Stanley from $158.00 to $163.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.45
31.07.25
31.07.25
€138.22
31.07.26
31.07.26
9.96%
19.09.25
19.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.50
22.07.25
22.07.25
€128.31
22.07.26
22.07.26
9.07%
19.09.25
19.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€105.00
07.03.25
07.03.25
€138.30
07.03.26
07.03.26
17.76%
19.09.25
19.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€148.00
04.02.25
04.02.25
€178.90
04.02.26
04.02.26
-16.45%
19.09.25
19.09.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.55
12.07.24
12.07.24
€155.89
12.07.25
12.07.25
-17.17%
13.07.25
13.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.65
12.06.24
12.06.24
€147.54
12.06.25
12.06.25
-14.64%
13.06.25
13.06.25